An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
Clinical trial NCT03446040 · TERMINATED
Trial details
- NCT number
- NCT03446040
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-08
- Primary completion
- 2024-08-29
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.